Piramal Pharma Limited (NSE: PPLPHARMA)

India flag India · Delayed Price · Currency is INR
226.31
+6.72 (3.06%)
Sep 6, 2024, 3:30 PM IST
116.25%
Market Cap 300.03B
Revenue (ttm) 83.73B
Net Income (ttm) 277.60M
Shares Out 1.33B
EPS (ttm) 0.21
PE Ratio n/a
Forward PE 93.64
Dividend 0.11 (0.05%)
Ex-Dividend Date Jul 12, 2024
Volume 31,772,886
Open 218.61
Previous Close 219.59
Day's Range 218.36 - 228.00
52-Week Range 87.50 - 228.00
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Oct 25, 2024

About Piramal Pharma

Piramal Pharma Limited operates as a pharmaceutical company in North America, Europe, Japan, India, and internationally. The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities and distribution network. It also operates contract development and manufacturing organization that provides services across the spectrum of the drug life cycle, including discovery, development, and commercial manufacturing of drug substances and products; complex hospital generics business which off... [Read more]

Sector Healthcare
Founded 2020
Employees 6,719
Stock Exchange National Stock Exchange of India
Ticker Symbol PPLPHARMA
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.